SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
MakeMyTrip Limited (MMYT) trades at a trailing P/E of 71.3, forward P/E of 60.7. Trailing earnings yield is 1.40%, forward earnings yield 1.65%. PEG 1.14.
Criteria proven by this page:
- VALUE (70/100, Pass) — analyst target implies upside (+103.9%).
- Forward P/E 60.7 (down from trailing 71.3) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 1.14 — between 1.0–2.0 indicates moderate valuation relative to growth.
- Trailing Earnings Yield 1.40% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 1.65% as earnings recover.
- Analyst consensus target $91.00 (+103.9% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 70/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
70/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
83/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — MMYT
Valuation Multiples
P/E (TTM)71.3
Forward P/E60.7
PEG Ratio1.14
Forward PEG1.14
P/B Ratio-14.28
P/S Ratio3.79
EV/EBITDA27.6
Per Share Data
EPS (TTM)$0.58
Forward EPS (Est.)$0.73
Book Value / Share$-2.86
Revenue / Share$10.64
FCF / Share$2.29
Yields & Fair Value
Earnings Yield1.40%
Forward Earnings Yield1.65%
Dividend Yield0.00%
SharesGrow IV$42.78 (-4.1%)
Analyst Target$91.00 (+103.9%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
-8.5 |
-0.02 |
9.72 |
2.25 |
- |
| 2017 |
-16.5 |
11.68 |
1.30 |
4.07 |
- |
| 2018 |
-14.9 |
-3.45 |
2.08 |
4.81 |
- |
| 2019 |
-17.1 |
0.65 |
2.11 |
5.90 |
- |
| 2020 |
-2.8 |
-0.02 |
1.46 |
2.46 |
- |
| 2021 |
-60.6 |
0.69 |
3.80 |
20.64 |
- |
| 2022 |
-63.9 |
3.32 |
3.24 |
9.54 |
- |
| 2023 |
-237.0 |
3.11 |
3.09 |
4.52 |
- |
| 2024 |
36.6 |
-0.02 |
7.14 |
10.14 |
- |
| 2025 |
116.0 |
-2.04 |
9.17 |
11.28 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$-2.12 |
$336.05M |
$-88.52M |
-26.3% |
| 2017 |
$-2.09 |
$447.62M |
$-110.17M |
-24.6% |
| 2018 |
$-2.18 |
$675.26M |
$-218.41M |
-32.3% |
| 2019 |
$-1.61 |
$486.01M |
$-167.76M |
-34.5% |
| 2020 |
$-4.25 |
$511.53M |
$-447.52M |
-87.5% |
| 2021 |
$-0.52 |
$163.44M |
$-56.04M |
-34.3% |
| 2022 |
$-0.42 |
$303.92M |
$-45.57M |
-15% |
| 2023 |
$-0.10 |
$593.04M |
$-11.17M |
-1.9% |
| 2024 |
$1.83 |
$782.52M |
$216.8M |
27.7% |
| 2025 |
$0.83 |
$978.34M |
$95.1M |
9.7% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$0.71 |
$0.66 – $0.75 |
$1.13B |
$1.08B – $1.17B |
4 |
| 2027 |
$1.02 |
$0.78 – $1.26 |
$1.33B |
$1.27B – $1.37B |
4 |
| 2028 |
$1.73 |
$1.63 – $1.81 |
$1.61B |
$1.54B – $1.66B |
3 |
| 2029 |
$0.00 |
$0.00 – $0.00 |
$1.99B |
$1.91B – $2.06B |
2 |
